Sign In
Buy TNDM
$18.03
-0.570 (-3.06%)
At Close: Jun 03, 2026
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
04:05pm, Monday, 04'th Mar 2024
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a global insulin delivery and diabetes technology company, announced today that it intends to offer, subject to market conditions
Why Tandem Diabetes Care Stock Popped Today
06:55pm, Thursday, 22'nd Feb 2024
Tandem Diabetes delivered weaker-than-expected Q4 results but followed with strong forward guidance. The company launched four new products in the U.S. last quarter.
Tandem Diabetes (TNDM) Posts Wider Q4 Loss, Gross Margin Down
09:36am, Thursday, 22'nd Feb 2024
Tandem Diabetes (TNDM) reports a higher-than-expected loss in the fourth quarter of 2023.
Tandem Diabetes Care, Inc. (TNDM) Q4 2023 Earnings Call Transcript
10:47pm, Wednesday, 21'st Feb 2024
Tandem Diabetes Care, Inc. (TNDM) Q4 2023 Earnings Call Transcript
Tandem Diabetes Care, Inc. (TNDM) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
07:01pm, Wednesday, 21'st Feb 2024
Although the revenue and EPS for Tandem Diabetes Care, Inc. (TNDM) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics com
Tandem Diabetes Care, Inc. (TNDM) Reports Q4 Loss, Misses Revenue Estimates
06:26pm, Wednesday, 21'st Feb 2024
Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to loss of $0.01 per share a year ago.
Tandem (TNDM) Broadens Insulin Pumps Line in the U.S. With Mobi
10:26am, Thursday, 15'th Feb 2024
Tandem's (TNDM) Mobi is claimed to be the world's smallest durable automated insulin delivery system.
Earnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q4 Earnings Expected to Decline
11:06am, Wednesday, 14'th Feb 2024
Tandem Diabetes Care, Inc. (TNDM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tandem Diabetes Care Announces Upcoming Conference Presentations
04:05pm, Thursday, 08'th Feb 2024
SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a comp
2 Beaten-Down Stocks That Are Worth Buying
07:30am, Sunday, 04'th Feb 2024
Not every company has kept pace with the rising market, but some laggards could prove winners. Tandem Diabetes Care's innovative devices and long runway for growth should help turn things around.
Tandem Diabetes Care to Announce Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024
04:05pm, Monday, 22'nd Jan 2024
SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its fourth quarter and full year 2
Tandem Diabetes (TNDM) and Abbott Debut New Integrated Offering
09:46am, Tuesday, 09'th Jan 2024
Tandem Diabetes' (TNDM) t:slim X2 is the first AID system to be integrated with Abbott's Freestyle Libre 2 Plus sensor.
Tandem is expected to have a lot of upside in 2024, says Jefferies' Matthew Taylor
02:34pm, Friday, 22'nd Dec 2023
Matthew Taylor, senior analyst at Jefferies, joins 'The Exchange' to discuss the outlook for the med tech market, his top picks for 2024, and more.
Here's Why You Should Retain Tandem Diabetes (TNDM) Now
09:02am, Tuesday, 19'th Dec 2023
Investors remain optimistic about Tandem Diabetes (TNDM), backed by the impressive spree of product introductions.
Tandem Diabetes (TNDM) Avails Tandem Source in the United States
12:47pm, Thursday, 14'th Dec 2023
Tandem Diabetes (TNDM) announces the full U.S. launch of Tandem Source, a new diabetes management platform for customers and healthcare providers.
